Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
16
Frequently Asked Questions
What is Market Cap of Chemomab Therapeutics Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Chemomab Therapeutics Ltd - ADR market cap is $15.69M.
What is the 52-week high for Chemomab Therapeutics Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Chemomab Therapeutics Ltd - ADR 52 week high is $9.84 as of September 14, 2025.
What is the 52-week low for Chemomab Therapeutics Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Chemomab Therapeutics Ltd - ADR 52 week low is $2.96 as of September 14, 2025.
What is Chemomab Therapeutics Ltd - ADR stock price today?
Chemomab Therapeutics Ltd - ADR stock price today is $3.03.
What was Chemomab Therapeutics Ltd - ADR stock price yesterday?
Chemomab Therapeutics Ltd - ADR stock price yesterday was $3.05.
What is the PE ratio of Chemomab Therapeutics Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Chemomab Therapeutics Ltd - ADR’s P/E ratio is -1.28.
What is the Price-to-Book ratio of Chemomab Therapeutics Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Chemomab Therapeutics Ltd - ADR P/B ratio is 1.6174.
What is the 50-day moving average of Chemomab Therapeutics Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Chemomab Therapeutics Ltd - ADR 50-day moving average is $3.90.
How many employess does Chemomab Therapeutics Ltd - ADR has?